logo
MPS lead crisis: Community leaders call for change outside clinic

MPS lead crisis: Community leaders call for change outside clinic

Yahoo08-05-2025

The Brief
Milwaukee Public Schools is in the midst of an ongoing lead hazard crisis.
Community leaders called for change outside a North Division screening clinic.
The health department is tasked with tackling the growing lead problem.
MILWAUKEE - Community leaders gathered outside North Division High School on Wednesday afternoon, calling for changes in the city, county, health department and school district amid an ongoing Milwaukee Public Schools lead hazard crisis.
"To advance policies that prioritize prevention of lead in children, whether in the school, the home, the water, the soil which folks are growing food to eat, and shift from a test-and-treat model to primary prevention," said Melody McCurtis, a Metcalfe Park neighborhood resident.
FREE DOWNLOAD: Get breaking news alerts in the FOX LOCAL Mobile app for iOS or Android
What they're saying
The Milwaukee Health Department is tasked with tackling the growing lead problem in MPS schools and bringing its facilities back into compliance after several lead closures and likely more to come.
"Based on our investigation, we're prioritizing lead paint and lead dust," said Milwaukee Health Commissioner Mike Totoraitis. "They have to return to compliance. That, inherently, is going to be a reactive process."
MHD is looking at school buildings built before 1978, prioritizing elementary schools as the age group most at risk for lead exposure. The scope of the problem is overwhelming.
"We're an old city with a lot of deeply-rooted challenges," said Tyler Weber, Milwaukee's deputy commissioner of environmental health. Those challenges include redlining, disinvestment, old construction and lack of staffing.
SIGN UP TODAY: Get daily headlines, breaking news emails from FOX6 News
By the numbers
Wednesday's lead screening clinic at North Division had the capacity to test 300 children. If there are positive tests, the challenge is to determine where that possible exposure occurred.
There are tens of thousands of children who live in Milwaukee, with 70,000 MPS students among them. Each year in the city, more than 1,200 kids test positive for lead poisoning with an average age of 3 years old.
But many more children are not getting tested, which means there are likely many more MPS students who have lead poisoning and don't know it.
So far, more than 1,400 children have been tested – including nearly 400 MPS students. Of that, the health department is investigating five potential lead poisonings. It's still unclear if that exposure happened in the home or at school.
What's next
Without additional funding or help from the federal government to hire more staff and expand the scope of the testing to be proactive, MHD said this is the most effective solution right now.
"It is a critical step in better understanding the potential exposure that students might have experienced in the school," said Totoraitis.
The Source
Information in this report is from the Milwaukee Health Department. FOX6 News also spoke to people at Wednesday's clinic at North Division High School.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

ASCO 2025: Key Updates in Early Breast Cancer Care
ASCO 2025: Key Updates in Early Breast Cancer Care

Medscape

time18 minutes ago

  • Medscape

ASCO 2025: Key Updates in Early Breast Cancer Care

Mariana Chavez MacGregor, MD, MSc, comments on how the ASCO 2025 meeting delivered a wealth of impactful data, particularly in the early-stage breast cancer setting. Trials like neoCARHP and CompassHER2 raised important questions about de-escalating therapy for HER2-positive patients, challenging the role of carboplatin and demonstrating strong pathologic complete response rates with shorter regimens. Long-term data from SOFT and TEXT reinforced the survival benefits of ovarian suppression plus an aromatase inhibitor in high-risk premenopausal patients, and the OASIS 4 study showed promise with elinzanetant in managing vasomotor symptoms. Across subtypes, including triple-negative disease, and with the growing role of AI and circulating tumor DNA, the meeting emphasized more personalized, less toxic approaches to care.

ASCO 2025: Key Highlights in Advanced Lung Cancer
ASCO 2025: Key Highlights in Advanced Lung Cancer

Medscape

time18 minutes ago

  • Medscape

ASCO 2025: Key Highlights in Advanced Lung Cancer

Just returned from ASCO 2025, Isabel Preeshagul, DO, comments on intriguing data that were presented, including results from REZILIENT1, which showed a 35% response rate for zipalertinib in patients with epidermal growth factor receptor exon 20-altered stage IV non-small cell lung cancer (NSCLC), even those previously treated with targeted therapies, with manageable toxicity. An unexpected finding from another study in the advanced NSCLC space suggested that administering immunochemotherapy before 3:00 PM was associated with better outcomes, possibly due to circadian influences on immune response. In extensive-stage small cell lung cancer, tarlatamab demonstrated superiority over chemotherapy in the DeLLphi-304 trial, with favorable patient-reported outcomes including improved cough and exertional shortness of breath. Finally, Dr Preeshagul notes how the IMforte study reported promising results for maintenance atezolizumab plus lurbinectedin, with improved progression-free survival and overall survival, making it a potential option pending further risk-benefit discussion.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store